FLOATER PROTECT MULTI AKTIENANLEIHE - NOVO-NORDISK B/ELI LILLY & CO/PFIZER INC FLOATER PROTECT MULTI AKTIENANLEIHE - NOVO-NORDISK B/ELI LILLY & CO/PFIZER INC Stock
Certificat
DE000VU87PF3
| Market Closed - Börse Stuttgart 02:39:13 2024-05-10 EDT | ||
| 76.13 EUR | +0.48% |
|
| Current month | +10.35% | ||
| 1 month | +5.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 76.13 | +0.48% | 0 |
| 24-05-09 | 75.77 | +2.20% | 0 |
| 24-05-08 | 74.14 | -1.79% | 0 |
| 24-05-07 | 75.49 | +1.29% | 0 |
| 24-05-06 | 74.53 | +0.20% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 02:39 am
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VU87PF |
| ISIN | DE000VU87PF3 |
| Date issued | 2023-07-24 |
| Strike | 459.3 $ |
| Maturity | 2024-06-21 (40 Days) |
| Parity | 0.46 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 102 € |
|---|---|
| Lowest since issue | 68.11 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
760
USD
Average target price
850.4
USD
Spread / Average Target
+11.90%
- Stock Market
- Certificates
- Certificat